Pharmaceuticals in France


November 21, 2012
35 Pages - SKU: MTLN4921109
License type:
Table of Contents Search inside this report Related Reports
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Pfizer Inc.
GlaxoSmithKline Plc
AstraZeneca PLC
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research
LIST OF TABLES
Table 1: France pharmaceuticals market value: $ billion, 2007–11
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2011
Table 3: France pharmaceuticals market share: % share, by value, 2011
Table 4: France pharmaceuticals market value forecast: $ billion, 2011–16
Table 5: Pfizer Inc.: key facts
Table 6: Pfizer Inc.: key financials ($)
Table 7: Pfizer Inc.: key financial ratios
Table 8: GlaxoSmithKline Plc: key facts
Table 9: GlaxoSmithKline Plc: key financials ($)
Table 10: GlaxoSmithKline Plc: key financials (£)
Table 11: GlaxoSmithKline Plc: key financial ratios
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: key financials ($)
Table 14: AstraZeneca PLC: key financial ratios
Table 15: France size of population (million), 2007–11
Table 16: France gdp (constant 2000 prices, $ billion), 2007–11
Table 17: France gdp (current prices, $ billion), 2007–11
Table 18: France inflation, 2007–11
Table 19: France consumer price index (absolute), 2007–11
Table 20: France exchange rate, 2007–11
LIST OF FIGURES
Figure 1: France pharmaceuticals market value: $ billion, 2007–11
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2011
Figure 3: France pharmaceuticals market share: % share, by value, 2011
Figure 4: France pharmaceuticals market value forecast: $ billion, 2011–16
Figure 5: Forces driving competition in the pharmaceuticals market in France, 2011
Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2011
Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2011
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2011
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2011
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2011
Figure 11: Pfizer Inc.: revenues & profitability
Figure 12: Pfizer Inc.: assets & liabilities
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: AstraZeneca PLC: revenues & profitability
Figure 16: AstraZeneca PLC: assets & liabilities
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Country Overviews Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!